Facebook Vice President David Marcus is the face of the company's Libra digital currency, but the original driving force was a 26-year-old female corporate-development...Technologyread more
Amazon's new policy for account suspensions doesn't go far enough to protect sellers from potentially unfair and wrongful suspensions, merchants say.Technologyread more
There is no end in sight to the Boeing 737 Max grounding after two fatal crashes, prompting airlines to rethink their growth plans.Airlinesread more
After a year of flooding, Midwest farmers face a stifling heat wave that's spreading across the U.S.Agricultureread more
A quarter of the S&P 500 companies report earnings next week, and that could buffet the market as investors await the July Fed meeting.Market Insiderread more
Moving lots of data to a public cloud over the internet can take months or years. CNBC got an inside look at how AWS transfers data to the cloud for its clients.Technologyread more
Iran's Revolutionary Guard claims a British tanker it still holds, Stena Impero, failed to follow international maritime rules.World Newsread more
"It troubles me that the most important political office in the world is becoming the face of racism and exclusion," Kaeser said in a Twitter post.Politicsread more
Silver's rally could be losing its shine after the precious metal reached its year-to-date high, futures experts warn.Futures Nowread more
Some 40% of Americans would struggle to come up with even $400 to pay for an emergency expense. Just how are so many Americans so short on cash? Blame debt.Personal Financeread more
Amazon hires Trump-allied lobbyist Jeff Miller as battle for Pentagon contract heats up.Politicsread more
Health-care stocks whipsawed on Friday as President Donald Trump unveiled his long-awaited plan to lower prescription drug prices, dubbed "American Patients First."
The sector briefly turned negative before closing 1.5 percent higher. Shares of Express Scripts and CVS both hit session lows before rising 2.6 percent and 3.2 percent, respectively. Dow Jones industrial average components Merck and UnitedHealth also dipped before trading higher upon the announcement.
The proposal seeks to boost competition, improve negotiation and create incentives to lower list prices of prescription drugs and lower out-of-pocket costs for consumers. It stopped short of allowing Medicare to directly work with manufacturers on prices.
Regeneron Pharmaceuticals was the best-performing stock in the health care sector, surging 6.2 percent. The company has a cholesterol drug that costs $14,000 a year. CEO Leonard Schleifer told CNBC in March he was hopeful a deal could be struck to lower the drug's cost.
Trump has repeatedly chastised drug companies. He's even accused them of "getting away with murder," spooking investors and causing pharmaceutical and biotech stocks to plunge.
"Everyone involved in the broken system — the drugmakers, insurance companies, distributions, pharmacy-benefit managers and many others — contribute to the problem," Trump said Friday. "Government has also been part of the problem because previous leaders turned a blind eye to this incredible abuse."
The SPDR Health Care ETF dipped briefly and then rebounded, up 1.5 percent after Trump's speech.
Jefferies analyst Jared Holz thought the announcement lacked details.
"This was a 10-to-15 minute speech where no real details were brought forward," Holz told CNBC. In a brief email sent to clients shortly after Trump's announcement, he said: "Jay-Z's Blueprint far more impactful than HHS version," referring to Jay-Z's hit album The Blueprint.